Connect with us

Published

on

Florida Gov. Ron DeSantis’s (R) decision to sign a controversial six-week abortion ban into law has put him in the middle of rough political terrain that Democrats and some Republicans say could undermine his White House ambitions in 2024.

DeSantis signed off on the measure Thursday hours after it won final approval from his state’s Republican-dominated House. In doing so, DeSantis further endeared himself to anti-abortion activists and hardline conservatives, who are certain to play a pivotal role in determining the GOP’s 2024 presidential nominee.

But the move could also carry potentially damning political consequences for DeSantis among a broader swath of the electorate that has repeatedly rejected rigid new restrictions on abortion in the months since the Supreme Court overturned Roe v. Wade, the landmark 1973 ruling that defined abortion rights in the U.S. for decades.

“I can’t understand what DeSantis’s political calculus is here,” said Jackson Peel, a spokesperson for Florida state House Democrats. “Once this ball started rolling, he couldn’t stop it. He either loses the primary or he loses the general over this issue.” 

While DeSantis touted the legislation as a win for the anti-abortion rights movement, there were also signs that the Florida governor is keenly aware of just how tricky abortion politics have become for the GOP. 

After praising the Supreme Court’s decision overturning Roe v. Wade last summer, he largely went quiet on the issue, offering little beyond vague pledges to “expand pro-life protections.” And though he had said prior to the six-week ban’s passage that he would sign the legislation, he did so with little fanfare in a small ceremony Thursday night.

“We are proud to support life and family in the state of Florida,” he said in a statement. “I applaud the Legislature for passing the Heartbeat Protection Act that expands pro-life protections and provides additional resources for young mothers and families.”

The precarious nature of abortion politics was put into stark relief in last year’s midterm elections, when Democrats seized on protecting abortion rights as a central theme of their campaigns and hammered Republicans for pushing new restrictions following the Supreme Court’s Dobbs ruling ending national abortion protections.

Following the midterms, former President Trump blamed the GOP’s lackluster performance squarely on the “abortion issue,” saying that it was “poorly handled by many Republicans, especially those that firmly insisted on No Exceptions, even in the case of Rape, Incest or Life of the Mother, that lost large numbers of Voters.”

The new law in Florida creates new exceptions for rape and incest up to 15 weeks of pregnancy and still allows exemptions for abortions deemed necessary for the health of the mother up to 15 weeks. And when — or whether — the new law goes into effect depends on how the state Supreme Court rules in a challenge to an earlier 15-week abortion ban signed into law last year.

Still, DeSantis has “been backed into a very difficult corner,” said Doug Heye, a Republican strategist, adding that, to an extent, DeSantis and every other GOP presidential hopeful is at the mercy of Republican-led state legislatures, who have sought to curb abortion access after the Dobbs decision.

“This may not hurt him in the primary, but clearly this puts Republicans in a position they wouldn’t want to be in in a general, and it makes it even harder to define Democrats as extremists on this issue,” Heye said.

“The Dobbs decision turned an issue in theory to an issue in practice,” he added. “So they’re having legislatures, whether in their states or other states, putting this issue out front.” 

As he moves toward a likely 2024 presidential campaign, the six-week ban could give DeSantis a leg up when it comes to courting anti-abortion activists and evangelicals, who remain deeply influential in Republican politics. Yet in a primary that many Republicans say should be about selecting the candidate most likely to win in 2024, the new abortion ban in Florida could open DeSantis up to new attacks.

“This isn’t a winning electoral messaging [for DeSantis],” one Republican pollster said. “It’s a given that you tack right to win the primary, but Republican voters are, I think, looking first and foremost at who can win; who can bring in those voters we lost last time around. And a lot of those voters have already said, ‘no, we don’t want more abortion bans.’”

Former Rep. Carlos Curbelo (R-Fla.), a moderate Republican who lost reelection in 2018, also warned that the new law could cost the GOP many of the suburban women voters that the party is hoping to win back after suffering defections to Democrats in recent years.

“You’re perhaps seeing Republicans overreach on a number of issues,” Curbelo said. “Especially with abortion, I’ve been hearing from a lot of suburban women here in Miami lately and they think Republicans are going too far.”

DeSantis is in a unique position among 2024 Republican presidential hopefuls. As a sitting governor, he’s in a position to actively push and sign legislation, while most other declared or prospective contenders — Trump and former United Nations Ambassador Nikki Haley, for instance — sit on the sidelines. 

Yet it puts DeSantis squarely at the center of a debate that many other Republican presidential hopefuls have sought to navigate delicately. During a stop in Iowa this week, for example, Haley reiterated that she is “pro-life,” but that she doesn’t “judge anyone who is pro-choice,” noting the deeply personal nature of the issue.

“What I mean is this is a personal issue for women and for men,” she said. “It needs to be treated with the respect that it should.”

Meanwhile, Sen. Tim Scott (R-S.C.), who launched a presidential exploratory committee this week, told NBC News on Friday that he would “sign the most conservative, pro-life legislation that they can get through Congress,” though he declined to say what such legislation would actually look like. Trump, for his part, has sought to dodge the issue as much as possible.

Keith Naughton, a veteran Republican strategist, said that DeSantis’s decision to sign the new abortion ban showed an effort to safeguard his political standing among conservatives at a time when many Republicans are rallying around Trump in the wake of the former president’s criminal indictment in New York. Community college enrollment plunges nearly 40 percent in a decade Nearly all Congressional Democrats urge Supreme Court to block abortion pill restrictions

While the legislation “doesn’t help [DeSantis] in a general,” Naughton said, the GOP is still more than a year away from picking its presidential nominee, leaving DeSantis plenty of time to let the fallout from the abortion ban cool down. 

“Politically, I think this is defensive. And it’s soon enough that maybe he can just get away from it for the rest of the campaign. I mean, he’s not going to run on it,” Naughton said. “For DeSantis, it just means he’s got to win on other issues. If he can win on the economy, he can survive this.”

“It’s a challenge,” Naughton said. “I don’t think anyone’s going to get stricter on the issue. Maybe he can sort of hold his breath and get through it.” 

Continue Reading

Business

UK economy grows – ONS

Published

on

By

UK economy grows - ONS

The economy performed better than expected in February, growing by 0.5% according to official figures released on Friday, but comes ahead of an expected hit from the global trade war.

The standard measure of an economy’s value, gross domestic product (GDP), rose in part thanks to a suprisingly strong performance from the manufacturing sector, data from the Office for National Statistics (ONS) suggested.

Following the publication of the figures, the British pound rose against the dollar, jumping 0.4% against the greenback to $1.3019 within an hour.

Analysts had been forecasting just a 0.1% GDP hike in the lead-up to the announcement, according to data from LSEG.

Chancellor of the Exchequer Rachel Reeves described the results as “encouraging”, but struck a cautious tone when alluding to US President Donald Trump’s tariffs, and the economic volatility of the past week.

“The world has changed, and we have witnessed that change in recent weeks,” she said.

“I know this is an anxious time for families who are worried about the cost of living and British businesses who are worried about what this change means for them,” Ms Reeves added. “This government will remain pragmatic and cool-headed as we seek to secure the best deal with the United States that is in our national interest.”

More on Uk Economy

But back in February, when Mr Trump was just beginning his second term in office, the UK’s economy looked to be on firmer ground.

Service sectors like computer programming, telecoms and car dealerships all had strong a month, while manufacturing industries such as electronics and pharmaceuticals also helped to drive GDP growth in February.

Car manufacturing also picked up after its recent poor performance.

“The economy grew strongly in February with widespread growth across both services and manufacturing industries,” said Liz McKeown, ONS Director of Economic Statistics.

While motor vehicle manufacturing and retail both grew in February 2025, they remain below February 2024 levels by 10.1% and 1.1% respectively

This aligns with industry data showing year-on-year declines in registrations and manufacturing.

“The UK economy expanded by 0.5% in February, surprising but welcome positive news,” said Hailey Low, Associate Economist at the National Institute of Economic and Social Research.

“However, heightened global uncertainty and escalating trade tensions mean the outlook remains uncertain, with a likely reduced growth rate this year due to President Trump’s “Liberation Day” announcements.”

Ms Low said that this could create a dilemma for Ms Reeves, who would face difficult decisions later in the year when the chancellor presents her next budget.

The latest data also shows a jump from January, when the economy was flat. And compared to the same month a year ago, GDP was 1.4% higher in February 2025.

You can receive breaking news alerts on a smartphone or tablet via the Sky News app. You can also follow us on WhatsApp and subscribe to our YouTube channel to keep up with the latest news.

Continue Reading

UK

‘I don’t look at myself as a dying person anymore’: New drug that slows incurable breast cancer now available on the NHS

Published

on

By

'I don't look at myself as a dying person anymore': New drug that slows incurable breast cancer now available on the NHS

A groundbreaking new cancer treatment, hailed by patients as “game-changing”, will be available via the NHS from today.

The drug capivasertib has been shown in trials to slow the spread of the most common form of incurable breast cancer.

Taken in conjunction with an already-available hormonal therapy, it has been shown in trials to double how long treatment will keep the cancer cells from progressing.

“I don’t look at myself anymore as a dying person,” says Elen Hughes, who has been using the drug since February this year.

“I look at myself as a thriving person, who will carry on thriving for as long as I possibly can.”

Ellen Hughes has been using the drug capivasertib
Image:
Elen Hughes says capivasertib has extended her life and improved its quality

Mrs Hughes, from North Wales, was first diagnosed with primary breast cancer in 2008.

Eight years later, then aged 46 and with three young children, she was told the cancer had returned and spread.

More on Cancer

She says that capivasertib, which she has been able to access via private healthcare, has not only extended her life but improved its quality with fewer side effects than previous medications.

It also delays the need for more aggressive blanket treatments like chemotherapy.

New breast cancer drug capivasertib
Image:
Capivasertib is now available from the NHS

“What people don’t understand is that they might look at the statistics and see that [the therapy] is effective for eight months versus two months, or whatever,” says Mrs Hughes.

“But in cancer, and the land that we live in, really we can do a lot in six months.”

Mrs Hughes says her cancer therapy has allowed her “to see my daughter get married” and believes it is “absolutely brilliant” that the new drug will be available to more patients via the NHS.

The National Institute for Health and Care Excellence approved capivasertib for NHS-use after two decades of research by UK teams.

Professor Nicholas Turner, from the Institute of Cancer Research which led the study, told Sky News it was a “great success story for British science”.

Professor Nicholas Turner, from the Institute of Cancer Research which led the study
Image:
Professor Nicholas Turner wants urgent genetic testing of patients with advanced breast cancers to see if they could benefit

The new drug is suitable for patients’ tumours with mutations or alterations in the PIK3CA, AKT1 or PTEN genes, which are found in approximately half of patients with advanced breast cancer.

Read more:
How AI could transform breast screening results
Breast cancer cases and deaths set to surge – study

Prof Turner says hundreds of patients could see the benefit in the immediate future, with thousands more people identified over time.

“We need new drugs that will help our existing therapies work for longer, and that’s where this new drug, capivasertib comes in,” says Prof Turner.

“It doubles how long hormone therapy treatment works for, giving patients precious extra time with their families.”

He called for urgent genetic testing of patients with advanced breast cancers to see if they could benefit.

Continue Reading

Politics

Grayscale and Osprey end 2-year legal fight over Bitcoin ETF promotion

Published

on

By

Grayscale and Osprey end 2-year legal fight over Bitcoin ETF promotion

Grayscale and Osprey end 2-year legal fight over Bitcoin ETF promotion

Asset managers Osprey Funds and Grayscale Investments agreed to settle a lawsuit over alleged violations of Connecticut law in the advertising and promotion of Grayscale’s Bitcoin exchange-traded fund (ETF). 

According to an April 9 court filing, the parties agreed to settle the two-year-old case and are finalizing documentation and settlement terms. The filing noted that once those steps are completed, Osprey will withdraw its appeal.

“Soon after this appeal was filed, the parties reached a settlement of this case,” the motion stated. “It is expected that all these tasks can be done within 45 days, and it is uncertain whether a shorter extension would suffice.”

Details of the settlement have not been made public. 

Grayscale and Osprey reach settlement

The legal battle between the two firms started on Jan. 30, 2023, when Osprey filed a suit in the Connecticut Superior Court. Osprey claimed it was Grayscale’s only competitor in the over-the-counter Bitcoin (BTC) trust market and that Grayscale had maintained its market share through deceit. 

Osprey claimed Grayscale promoted its Grayscale Bitcoin Trust (GBTC) as a means to access a spot Bitcoin ETF through a conversion. Osprey argued that the conversion was presented as a certainty, despite regulatory uncertainty at the time.

Grayscale’s application to convert GBTC into a spot ETF was approved by the US Securities and Exchange Commission in January 2024.

An August 2023 ruling compelled the SEC to reconsider its rejection of Grayscale’s application to convert the fund into an ETF. 

The SEC’s approval allowed GBTC to transition into a spot ETF and begin trading on the NYSE Arca exchange.

Related: Crypto ETPs shed $240M last week amid US trade tariffs — CoinShares

Lawsuit settlement follows Osprey appeal 

On Feb. 7, Judge Mark Gould sided with Grayscale, ruling that Osprey’s claims against the asset manager were exempted from the Connecticut Unfair Trade Practices Act. 

Osprey responded by filing a motion for reargument on Feb. 10. The fund claimed that Gould’s ruling came “before the close of discovery,” which is the formal evidence-gathering phase of a lawsuit.

The fund claimed that the ruling overlooked the differences between how the Federal Trade Commission and Connecticut courts treat deceptive advertising. 

The settlement ended one of the more prominent legal clashes among crypto asset managers competing for early ETF dominance. Grayscale’s GBTC remains one of the largest Bitcoin investment vehicles in the United States.

Magazine: Illegal arcade disguised as … a fake Bitcoin mine? Soldier scams in China: Asia Express

Continue Reading

Trending